open-label placebo
Sponsors
Massachusetts General Hospital, University Hospital, Basel, Switzerland, Universitätsklinikum Hamburg-Eppendorf, Studio Osteopatico Busto Arsizio, University of California, San Francisco
Conditions
Adolescent Idiopathic Scoliosis (AIS)AntidepressantsChronic Low-back PainChronic PainDepressive SymptomsExpectancyExpectationsLow Back Pain, Recurrent
Phase 2
Unknown Phase
Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo
CompletedNCT02578420
Start: 2016-01-31End: 2017-06-30Updated: 2017-07-26
Open-Label Placebo Treatment for Acute Postoperative Pain
CompletedNCT04339023
Start: 2020-05-12End: 2023-01-31Updated: 2023-08-22
Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation Symptoms
CompletedNCT05051995
Start: 2022-02-17End: 2024-05-15Updated: 2024-06-12
Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis
RecruitingNCT06365892
Start: 2024-07-01End: 2026-12-01Target: 64Updated: 2026-03-13
HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain
CompletedNCT06931158
Start: 2025-03-10End: 2026-06-19Updated: 2026-07-23
Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy
RecruitingNCT07373210
Start: 2026-12-01End: 2028-03-31Target: 64Updated: 2026-04-29